133142-08-2

Upstream product

• 947-84-2 2-Biphenylcarboxylic acid 
• 109-52-4 valeric acid 
• 95-54-5 1,2-diamino-benzene 
• 28742-67-8 2-butyl-5-nitro-1H-benzo[d]imidazole 
• 5851-44-5 2-n-butylbenzimidazole 
• 667457-40-1 4-acetamidomethylbiphenyl-2'-carboxylic acid 
• 667457-41-2 4-(chloromethyl)biphenyl-2'-carboxylic acid 
• 133142-71-9 4'-(2-butyl-5-nitro-benzoimidazol-1-ylmethyl)-biphenyl-2-carboxylic acid 

Downstream Products

• 1078723-60-0 4'-(2-butyl-5-pentanoylamino-benzoimidazol-1-yl-methyl)-biphenyl-2-carboxylic acid 
• 1078723-57-5 4'-(2-butyl-5-propionylamino-benzoimidazol-1-yl-methyl)-biphenyl-2-carboxylic acid 
• 133141-78-3 4'-(2-butyl-5-butyrylamino-benzoimidazol-1-yl-methyl)-biphenyl-2-carboxylic acid 
• 1078723-66-6 4'-[2-butyl-5-(4-chloro-benzoylamino)-2-butyl-benzoimidazol-1-yl-methyl]-biphenyl-2-carboxylic acid 
• 1078723-62-2 4'-(5-benzoylamino-2-butyl-benzoimidazol-1-yl-methyl)-biphenyl-2-carboxylic acid 
• 1078723-64-4 4'-[2-butyl-5-(2-chloro-benzoylamino)-2-butyl-benzoimidazol-1-yl-methyl]-biphenyl-2-carboxylic acid 

Relevant academic research and scientific papers

Design, synthesis, and evaluation of novelly substituted benzimidazole compounds as angiotensin II receptor antagonists

5-Nitrobenzimidazole derivatives with varying substituents at 2-position have been designed, synthesized, and evaluated for angiotensin II antagonistic activity. A drug-receptor interaction model has been proposed.